Latest: Watch here for details of new products and services.
- About Us
- Pharmalicensing - Open Innovation for the life sciences
- Our Products
- Overview
- Partnering Search
- Company Profiling
- Partneringtools
- Reports
- Partnering Consulting
- Due Diligence
- Comparison
- Due Diligence
- Overview
- Top Applications
- Online Panel Discussions
- Request Consultation
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire
- Jobs
- Forums
- Contact Pharmalicensing
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
Pharmalicensing Ltd
is a division of
is a division of
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
The University of Edinburgh has perfected a genetic engineering strategy in mouse embryonic stem cells to replace large regions of mouse chromosomal sequences (>100kb) with the corresponding human syntenic region. More
A non-invasive development of a test for the diagnosis and monitoring of endometriosis. More
Cliovelle - a low dose Estradiol / Progestin combination product for treatment of menopausal disorders. More
Currently, LTS has two matrix formulation under development varying in their manufacturing process More
Western inventors have identified a group of 12 differentially expressed proteins in Preeclampsia (PE) patients using a state-of-art proteomics based approach. More
The University of Edinburgh has developed a new method of screening for polymorphs and solvates of drug compounds that has potential to revolutionise the way polymorph screening is conducted. More
A new method for screening for enantiomeric excess which is colorimetric, rapid and sensitive. More
New substituted phenyl compounds useful for the treatment of respiratory disorders e.g. extrinsic or intrinsic or atopic asthma, chronic bronchitis, bronchiectasis and emphysema - multifunctional ?-agonist compounds comprising a reactive oxygen... More
These compounds can be used to treat hypogonadism, as hormonal therapy and as a male contraceptive. More
This invention concerns the oral and intravenous administration of sodium 2-mercaptoethylsulfonate (MESNA) in the treatment of hyperhomocysteinemia. More
Your selection
Browse By
- Industry sector
- Generics
- Nutrition
- OTC/Non-Prescription
- Pediatric
- Personal Care
- Prescription
- Therapeutic target
- Gender related medicine female
- Gender related medicine male
- Genito-urinary other
- Paget's disease
- Sexually transmitted diseases
- Urinary
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1995-2008 Pharmalicensing Ltd, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us